CollaGenex (CGPI) FDA PENDING Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CollaGenex (CGPI) FDA PENDING

CGPI 0.0001000

0.0%

Jul 21 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: thomas larkin who wrote (27)	4/18/1998 6:32:00 AM
From: Vector1	of 142

the amount of antibiotic in periostat is too small to kill bacteria thus there should be no issue of resistance. The company has submitted a ton of info on this to the FDA. Periostat works by inhibiting the enzyme that breaks down the gum tissue, not by killing the bacteria. Your point is well taken in that the fear on this point is depressing the stock IMO. V1

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next